Humana (HUM) stock jumps as the company with its Q2 results lifts its 2025 outlook, citing strength in its Medicare Advantage ...

Humana's Q2 2025 earnings showcase raised EPS guidance, driven by CenterWell Pharmacy outperformance and MA membership gains.

Humana raised its full-year outlook as it anticipates a smaller decline in Medicare Advantage membership than originally ...

Humana's senior-focused primary care unit is set to acquire The Villages Health, which provides care to the large Florida-based retirement community.

Humana’s results showed GAAP revenue growth and a non-GAAP earnings beat against analyst expectations. Revenue climbed by approximately 9.6% year over year to $32.4 billion (GAAP). However, adjusted ...

In conclusion, Humana’s earnings call conveyed a positive outlook, driven by strong performances in key areas like CenterWell Pharmacy and improved membership retention. While challenges such as Stars ...

Humana raised its annual profit forecast after beating quarterly estimates on Wednesday, as the U.S. health insurer succeeded ...

July 30, 2025Humana Inc. misses on earnings expectations. Reported EPS is $6.27 EPS, expectations were $6.32. Operator: Good ...

Humana is raising its full-year guidance after surpassing revenue expectations in the second quarter, the insurer announced ...

The Kentucky-based company’s results are a bright spot in what’s otherwise been a gloomy quarter for health insurers. Humana ...

Humana lowered its full-year 2025 GAAP EPS guidance to approximately $13.77, down from $14.68. At the same time, it raised ...

Humana beat Q2 EPS and revenue estimates and raised its 2025 outlook, driven by strong PDP growth and higher CenterWell patient volumes.